Format
Sort by
Items per page

Send to

Choose Destination

Best matches for von Weizsäcker F[au]:

[Prions]. Wieland S et al. Dtsch Med Wochenschr. (1996)

[From Molecuar to Natural Medicine]. Allgaier HP et al. Dtsch Med Wochenschr. (2018)

[Hereditary hemochromatosis]. Arnold C et al. Dtsch Med Wochenschr. (1998)

Search results

Items: 1 to 50 of 82

1.

[From Molecuar to Natural Medicine].

Allgaier HP, Arnold C, Baumert TF, Becker G, Geißler M, Hafkemeyer P, Harder J, Heim MH, Huber R, Kern WV, Mohr L, Moradpour D, Offensperger S, Offensperger WB, Spangenberg HC, Thimme R, Walter E, von Weizsäcker F.

Dtsch Med Wochenschr. 2018 Jan;143(1):40-45. doi: 10.1055/s-0043-123263. Epub 2018 Jan 9. German. No abstract available.

PMID:
29316584
2.

Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany.

Sinn M, Bischoff S, Nehls O, Pelzer U, von Weizsäcker F, Kubicka S, Stieler JM, Caca K, Riess H.

Onkologie. 2012;35(12):755-60. doi: 10.1159/000345115. Epub 2012 Nov 20.

3.

Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes.

Zellmer S, Schmidt-Heck W, Godoy P, Weng H, Meyer C, Lehmann T, Sparna T, Schormann W, Hammad S, Kreutz C, Timmer J, von Weizsäcker F, Thürmann PA, Merfort I, Guthke R, Dooley S, Hengstler JG, Gebhardt R.

Hepatology. 2010 Dec;52(6):2127-36. doi: 10.1002/hep.23930. Epub 2010 Oct 26.

PMID:
20979052
4.

[Ethical insolvency?].

von Weizsäcker F, Maio G.

Dtsch Med Wochenschr. 2010 Apr;135(16):819-21. doi: 10.1055/s-0030-1251937. Epub 2010 Apr 13. German.

PMID:
20391316
5.

Switch from type II to I Fas/CD95 death signaling on in vitro culturing of primary hepatocytes.

Walter D, Schmich K, Vogel S, Pick R, Kaufmann T, Hochmuth FC, Haber A, Neubert K, McNelly S, von Weizsäcker F, Merfort I, Maurer U, Strasser A, Borner C.

Hepatology. 2008 Dec;48(6):1942-53. doi: 10.1002/hep.22541.

6.

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

Petersen J, Dandri M, Mier W, Lütgehetmann M, Volz T, von Weizsäcker F, Haberkorn U, Fischer L, Pollok JM, Erbes B, Seitz S, Urban S.

Nat Biotechnol. 2008 Mar;26(3):335-41. doi: 10.1038/nbt1389. Epub 2008 Feb 24.

PMID:
18297057
7.

Inhibition of GSK3 differentially modulates NF-kappaB, CREB, AP-1 and beta-catenin signaling in hepatocytes, but fails to promote TNF-alpha-induced apoptosis.

Götschel F, Kern C, Lang S, Sparna T, Markmann C, Schwager J, McNelly S, von Weizsäcker F, Laufer S, Hecht A, Merfort I.

Exp Cell Res. 2008 Apr 1;314(6):1351-66. doi: 10.1016/j.yexcr.2007.12.015. Epub 2007 Dec 31.

PMID:
18261723
8.

Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.

Baumert TF, Rösler C, Malim MH, von Weizsäcker F.

Hepatology. 2007 Sep;46(3):682-9.

PMID:
17625792
9.

Pathogenesis of hepatitis B virus infection.

Baumert TF, Thimme R, von Weizsäcker F.

World J Gastroenterol. 2007 Jan 7;13(1):82-90. Review.

10.

Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways.

Klingmüller U, Bauer A, Bohl S, Nickel PJ, Breitkopf K, Dooley S, Zellmer S, Kern C, Merfort I, Sparna T, Donauer J, Walz G, Geyer M, Kreutz C, Hermes M, Götschel F, Hecht A, Walter D, Egger L, Neubert K, Borner C, Brulport M, Schormann W, Sauer C, Baumann F, Preiss R, MacNelly S, Godoy P, Wiercinska E, Ciuclan L, Edelmann J, Zeilinger K, Heinrich M, Zanger UM, Gebhardt R, Maiwald T, Heinrich R, Timmer J, von Weizsäcker F, Hengstler JG.

Syst Biol (Stevenage). 2006 Nov;153(6):433-47.

PMID:
17186705
11.

Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.

Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizsäcker F, Blum HE, Pircher H, Thimme R.

J Virol. 2007 Jan;81(2):945-53. Epub 2006 Nov 1.

12.

Host cell responses induced by hepatitis C virus binding.

Fang X, Zeisel MB, Wilpert J, Gissler B, Thimme R, Kreutz C, Maiwald T, Timmer J, Kern WV, Donauer J, Geyer M, Walz G, Depla E, von Weizsäcker F, Blum HE, Baumert TF.

Hepatology. 2006 Jun;43(6):1326-36.

13.

Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes.

Tomai E, Butz K, Lohrey C, von Weizsäcker F, Zentgraf H, Hoppe-Seyler F.

J Biol Chem. 2006 Jul 28;281(30):21345-52. Epub 2006 May 22.

14.

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.

Neumann-Haefelin C, McKiernan S, Ward S, Viazov S, Spangenberg HC, Killinger T, Baumert TF, Nazarova N, Sheridan I, Pybus O, von Weizsäcker F, Roggendorf M, Kelleher D, Klenerman P, Blum HE, Thimme R.

Hepatology. 2006 Mar;43(3):563-72.

PMID:
16496339
15.

Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.

Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, Roggendorf M, von Weizsäcker F, Blum HE, Thimme R.

Hepatology. 2005 Oct;42(4):828-37.

PMID:
16175596
16.

APOBEC-mediated interference with hepadnavirus production.

Rösler C, Köck J, Kann M, Malim MH, Blum HE, Baumert TF, von Weizsäcker F.

Hepatology. 2005 Aug;42(2):301-9.

PMID:
16025511
17.

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C, Blum HE, von Weizsäcker F, Thimme R.

J Virol. 2005 Jun;79(12):7860-7.

18.

[Management of chronic hepatitis B].

von Weizsäcker F.

Praxis (Bern 1994). 2005 Apr 20;94(16):649-52. Review. German.

PMID:
15900829
19.

Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.

Barth H, Cerino R, Arcuri M, Hoffmann M, Schürmann P, Adah MI, Gissler B, Zhao X, Ghisetti V, Lavezzo B, Blum HE, von Weizsäcker F, Vitelli A, Scarselli E, Baumert TF.

J Virol. 2005 May;79(9):5774-85.

20.

Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.

Baumert TF, Yang C, Schürmann P, Köck J, Ziegler C, Grüllich C, Nassal M, Liang TJ, Blum HE, von Weizsäcker F.

Hepatology. 2005 Feb;41(2):247-56.

PMID:
15660384
21.

Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes.

Dandri M, Burda MR, Zuckerman DM, Wursthorn K, Matschl U, Pollok JM, Rogiers X, Gocht A, Köck J, Blum HE, von Weizsäcker F, Petersen J.

J Hepatol. 2005 Jan;42(1):54-60.

PMID:
15629507
22.
23.

Comment on "Inhibition of hepatitis B virus replication by APOBEC3G".

Rösler C, Köck J, Malim MH, Blum HE, von Weizsäcker F.

Science. 2004 Sep 3;305(5689):1403; author reply 1403. No abstract available.

24.

Out of control: hepatitis B reactivation by transarterial treatment of hepatocellular carcinoma.

von Weizsäcker F, Blum HE.

J Hepatol. 2004 Sep;41(3):482-4. Review. No abstract available.

PMID:
15336452
25.

[Procedures for problematic situations with hepatitis B].

Blum HE, Berg T, Tillmann HL, Von Weizsäcker F.

Z Gastroenterol. 2004 Aug;42(8):692-7. Review. German. No abstract available.

PMID:
15314717
26.

[Best supportive care of hepatocellular carcinoma].

Spangenberg HC, Thimme R, Von Weizsäcker F, Blum HE.

Internist (Berl). 2004 Jul;45(7):777-85. Review. German.

PMID:
15160245
27.

[The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].

Panther E, Spangenberg HC, Neumann-Haefelin C, Rösler K, Blum HE, von Weizsäcker F, Thimme R.

Z Gastroenterol. 2004 Jan;42(1):39-46. Review. German.

PMID:
14997402
28.

The tupaia model for the study of hepatitis B virus: direct infection and HBV genome transduction of primary tupaia hepatocytes.

von Weizsäcker F, Köck J, MacNelly S, Ren S, Blum HE, Nassal M.

Methods Mol Med. 2004;96:153-61. No abstract available.

PMID:
14762267
29.

[Systemic treatment for hepatocellular carcinoma].

Spangenberg HC, Zuber-Jerger I, Thimme R, Blum HE, Von Weizsäcker F.

Zentralbl Chir. 2003 Nov;128(11):906-10. Review. German.

PMID:
14669110
30.

Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes.

Köck J, Baumert TF, Delaney WE 4th, Blum HE, von Weizsäcker F.

Hepatology. 2003 Dec;38(6):1410-8.

PMID:
14647052
31.

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.

Barth H, Schafer C, Adah MI, Zhang F, Linhardt RJ, Toyoda H, Kinoshita-Toyoda A, Toida T, Van Kuppevelt TH, Depla E, Von Weizsacker F, Blum HE, Baumert TF.

J Biol Chem. 2003 Oct 17;278(42):41003-12. Epub 2003 Jul 16.

32.

Central role of a serine phosphorylation site within duck hepatitis B virus core protein for capsid trafficking and genome release.

Kock J, Kann M, Putz G, Blum HE, Von Weizsacker F.

J Biol Chem. 2003 Jul 25;278(30):28123-9. Epub 2003 May 10.

33.

Pancreatico-mediastinal fistula with a mediastinal mass lesion demonstrated by MR imaging.

Oksüz MO, Altehoefer C, Winterer JT, Windfuhr-Blum M, Kleinschmidt M, von Weizsäcker F, Ochs A, Langer M.

J Magn Reson Imaging. 2002 Dec;16(6):746-50.

PMID:
12451589
34.

[T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma].

Thimme R, Spangenberg HC, Von Weizsäcker F, Blum HE.

Dtsch Med Wochenschr. 2002 Oct 25;127(43):2277-9. German. No abstract available.

PMID:
12397543
35.

[Prevention of hepatocellular carcinoma].

von Weizsäcker F, Allgaier HP, Blum HE.

Praxis (Bern 1994). 2002 Aug 28;91(35):1393-5. German.

PMID:
12233281
36.

Virus replication and virion export in X-deficient hepatitis B virus transgenic mice.

Reifenberg K, Nusser P, Löhler J, Spindler G, Kuhn C, von Weizsäcker F, Köck J.

J Gen Virol. 2002 May;83(Pt 5):991-6.

PMID:
11961252
37.

Inhibition of duck hepatitis B virus replication by intrahepatic expression of an antiviral resistance gene.

Kündgen LR, Thoma C, Köck J, Wilting J, Koch K, Offensperger WB, Blum HE, von Weizsäcker F.

J Mol Med (Berl). 2002 Mar;80(3):187-95. Epub 2001 Nov 22.

PMID:
11894145
38.

Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection.

Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Barth H, Levy S, von Weizsäcker F, Blum HE, Baumert TF.

J Clin Invest. 2002 Jan;109(2):221-32.

39.

Cis-preferential recruitment of duck hepatitis B virus core protein to the RNA/polymerase preassembly complex.

von Weizsäcker F, Köck J, Wieland S, Beck J, Nassal M, Blum HE.

Hepatology. 2002 Jan;35(1):209-16.

PMID:
11786978
40.

[Current status of cell-based therapies in liver diseases].

Petersen J, Ott M, von Weizsäcker F.

Z Gastroenterol. 2001 Nov;39(11):975-80. German.

PMID:
11778158
41.

Generation of stable mRNA fragments and translation of N-truncated proteins induced by antisense oligodeoxynucleotides.

Thoma C, Hasselblatt P, Köck J, Chang SF, Hockenjos B, Will H, Hentze MW, Blum HE, von Weizsäcker F, Offensperger WB.

Mol Cell. 2001 Oct;8(4):865-72. Erratum in: Mol Cell 2002 Jan;9(1):following 201.

42.

Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice.

Geissler M, Mohr L, Weth R, Köhler G, Grimm CF, Krohne TU, von Weizsäcker F, Blum HE.

Gastroenterology. 2001 Oct;121(4):931-9.

PMID:
11606506
43.

Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection.

Balkow S, Kersten A, Tran TT, Stehle T, Grosse P, Museteanu C, Utermöhlen O, Pircher H, von Weizsäcker F, Wallich R, Müllbacher A, Simon MM.

J Virol. 2001 Sep;75(18):8781-91.

44.

Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus.

Köck J, Nassal M, MacNelly S, Baumert TF, Blum HE, von Weizsäcker F.

J Virol. 2001 Jun;75(11):5084-9.

45.

Trypsinogen gene mutations in patients with chronic or recurrent acute pancreatitis.

Truninger K, Köck J, Wirth HP, Muellhaupt B, Arnold C, von Weizsäcker F, Seifert B, Ammann RW, Blum HE.

Pancreas. 2001 Jan;22(1):18-23.

46.

[Cell transplantation in hepatology].

von Weizsäcker F.

Praxis (Bern 1994). 2000 Oct 26;89(43):1749-52. German.

PMID:
11103620
47.

Ligand-mediated retargeting of recombinant adenovirus for gene transfer in vivo.

Thoma C, Wieland S, Moradpour D, von Weizsäcker F, Offensperger S, Madon J, Blum HE, Offensperger WB.

Gene Ther. 2000 Jun;7(12):1039-45.

48.

Antisense oligonucleotide therapy of hepadnavirus infection.

Offensperger WB, Thoma C, Moradpour D, von Weizsäcker F, Offensperger S, Blum HE.

Methods Enzymol. 2000;314:524-36. No abstract available.

PMID:
10565037
49.

Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis.

von Weizsäcker F, Köck J, Wieland S, Offensperger WB, Blum HE.

Hepatology. 1999 Jul;30(1):308-15.

PMID:
10385672

Supplemental Content

Loading ...
Support Center